RXRX Recursion Pharmaceuticals In

held by 1 manager in Q1 2022

Manager	% of their portfolio	Held	Activity	Value	Shares
Stanley Druckenmiller Duquesne Family Office	0.09%	9 mo	Add 5.3%	$2M	273,650

Search